Brian Thompson, CEO of Unitedhealthcare.
Courtesy: UnitedHealth Group
A group of investors demanded Unitedhealthcare group On Wednesday, accusing the company to deceive them after the murder of its CEO, Brian Thompson.
The collective demand, presented in the Southern District of New York, accuses the health insurance company of not initially adjusting its 2025 net profit perspective to take into account how Thompson's murder would affect its operations.
On December 3, one day before Thompson was a fatal shot, the company issued a guide that included net earnings of $ 28.15 to $ 28.65 per action and adjusted net profits from $ 29.50 to $ 30.00 per share, the demand indicates. And on January 16, the company announced that it was staying with its former prognosis.
Investors described this as “materially false and misleading”, pointing out the immense public scrutiny of the company and the broader health insurance industry experienced due to Thompson's murder.
The group, which seeks unspecified damage, argued that the public reaction prevented the company from pursuing “aggressive and anticonsumeral tactics that would need to achieve” its profits.
“As such, the company was deliberately reckless in duplicating its guide issued above,” says the demand.
The company finally reviewed its 2025 perspective on April 17, citing a necessary change in the corporate strategy, a measure that made its actions fall more than 22% that day.
UnitedHealthcare did not immediately respond a comment request on Thursday.
Thompson's fatal shooting in New York City streets in broad daylight sent shock waves throughout the country.
Luigi Mangione, the 27 -year -old man accused of murder, declared himself innocent of federal and state charges against him. The legal defense fund for Mangione exceeded the $ 1 million mark in donations on Tuesday.
